Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 5, 1996, Pages 346-349

  Crampette, L ^a   Mainprice, B ^b   Bloom, M ^c   Bousquet, J ^d   Campbell, A M ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c Marion Merrell Dow SA   (France)

^d INSERM   (France)

Author keywords

Cytokine; Leukotriene; Nasal polyp; Terfenadine

Indexed keywords

ANTIALLERGIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEUKOTRIENE; TERFENADINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; NOSE POLYP; PRIORITY JOURNAL;

EID: 0030036654     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04622.x     Document Type: Article

References (20)

1. Bousquet J, Lebel B, Chanal I, Morel A, Michel FB. Antiallergic activity of H,-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988;82:881-7.
2. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D. Terfenadine, an H, antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142:167-71.
3. Lai CK, Beasley R, Holgate ST. The effect of an increase in inhaled allergen dose after terfenadine on the occurrence and magnitude of the late asthmatic response. Clin Exp Allergy 1989;19:209-16.
4. Hamid M, Rafferty P, Holgate ST. The inhibitory effect of terfenadine and flurbiprofen on early and late-phase bronchoconstriction following allergen challenge in atopic asthma. Clin Exp Allergy 1990;20:261-7.
5. Nabe M, Agrawal DK, Sarmiento EU, Townley RG. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy 1989;19:515-20.
6. Campbell AM, Chanez P, Marty-Ane C, et al. Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine. Allergy 1993;48:125-9.
7. de Weck AL, Derer T, Bischoff SC, Takafuji S. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. Int Arch Allergy Immunol 1993;101:326-32.
8. Tos M, Sasaki Y, Ohnishi M, Larsen P, Drake-Lee AB. Fireside Conference 2. Pathogenesis of nasal polyps. Rhinol Suppl 1992;14:181-5.
9. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89:1662-8.
10. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PL. Increased expression of CDllb and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993;150:4061-71.
11. Xaubet A, Mullol J, Lopez E, et al. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on i in vitro eosinophil urvival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994;24:307-17.
12. Furukawa M, Yamashita T, Kumazawa T, Satouchi K, Saito K. Evidence of platelet-activating factor in nasal 1 polyps. ORL J Otorhinolaryngol Relat Spec 1992;54:29-32.
13. Ogino S, Irifune M, Harada T, Kikumori H, Matsunaga ] T. Arachidonic acid metabolites in human nasal polyps. Acta Otolaryngol Suppl (Stockh) 1993;501:85-7.
14. Finotto S, Dolovich J, Denburg JA, Jordana M, Marshall ; JS. Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue. Clin | Exp Immunol 1994;95:343-50.
15. Hamaguchi Y, Suzumura H, Arima S, Sakakura Y. Quantitation and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis. Int Arch Allergy Immunol 1994;104:155-9.
16. Konno S, Adachi M, Asano K, Matsuo S, Okamoto K, Takahashi T. Inhibitory action of azelastine on cytokine production from human peripheral blood leukocytes in rilro. Life Sei 1993;53:L201-6.
17. Hamamoto Y, Nagai K, Muto M, Asagami C. Inhibitory effect of azelastine, a potent antiallergic agent, on release of tumor necrosis factor-alpha from activated human peripheral blood mononuclear cells and U937 cells. Exp Dermatol 1993;2:231-5.
18. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994;149:339-44.
19. Brooks CD, Karl KJ, Francom SF. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990; 20:21-6.
20. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-89.